Home
CoStim Pharmaceuticals

CoStim Pharmaceuticals Market Share Analysis for February 2026

In COSTIM RE, crediamo che la trasformazione urbana debba generare valore sostenibile. Il nostro approccio industriale unisce competenze specialistiche e tecnologie avanzate, per dare vita a nuovi spazi e possibilità.

Industry: N/A

Domaincostim.com

Year Founded2019

Employees201 - 500

Annual Revenue--

CoStim Pharmaceuticals

CoStim Pharmaceuticals (including company regionals)

costim.com

See more website traffic and engagement information

Total visits to CoStim Pharmaceuticals's top domains

Understand CoStim Pharmaceuticals market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

costim.com603

See more with Sales Intelligence

Avg. visit duration in CoStim Pharmaceuticals's top domains

Analyze CoStim Pharmaceuticals engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

costim.com00:01:03

See more with Sales Intelligence

Avg. pageviews on CoStim Pharmaceuticals's top domains

See how CoStim Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

costim.com2.04

See more with Sales Intelligence

CoStim Pharmaceuticals top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by CoStim Pharmaceuticals

These are the website technologies, by industry, used by CoStim Pharmaceuticals top domains

Social (4)

Instagram

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

More Technologies

7

See all

News & Signals from CoStim Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovartis Pharmaceuticals Corporation acquired CoStim Pharmaceuticals Inc. on Jan 1st '12.MPM and Dana-Farber said they have previously launched companies together, including CoStim Pharmaceuticals, which was acquired by Novartis, and Tizona Therapeutics, which has a collaboration with AbbVie.